Chapters

Transcript

Video

Candid On Cancer: Interview with Penn Medicine's Dr. Robert Vonderheide - Impact of the ACC

Penn Medicine's Dr. Robert Vonderheide, Director of the Abramson Cancer Center, discusses the FDA-approved cancer therapies developed at Penn Medicine that are now available to patients worldwide. 

Twitter @PennMDForum

Related Presenters

Robert Vonderheide, MD, DPhil.

Robert Vonderheide, MD, DPhil

Medical Oncology

Dr. Vonderheide is an internationally renowned cancer immunotherapy and translational research expert. Through a focus on novel immunotherapies for pancreatic cancer, melanoma and breast cancers, Dr. Vonderheide has mapped new models for ...

View full profile

ADVERTISEMENT

Related Videos